{"id":"gw640385","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL206031","moleculeType":"Small molecule","molecularWeight":"703.84"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"GW640385 works by inhibiting the HIV-1 integrase enzyme, which is essential for the integration of viral DNA into the host genome, thereby preventing the replication of the virus.","oneSentence":"GW640385 is a HIV-1 integrase inhibitor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:40:17.502Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of HIV-1 infection"}]},"trialDetails":[{"nctId":"NCT00242879","phase":"PHASE2","title":"A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults","status":"TERMINATED","sponsor":"ViiV Healthcare","startDate":"2005-08","conditions":"Infection, Human Immunodeficiency Virus I, HIV-1 Infection","enrollment":130},{"nctId":"NCT00257621","phase":"PHASE2","title":"GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2004-10","conditions":"Infection, Human Immunodeficiency Virus I, HIV Infection","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"GW640385","genericName":"GW640385","companyName":"ViiV Healthcare","companyId":"viiv-healthcare","modality":"Small molecule","firstApprovalDate":"","aiSummary":"GW640385 is a HIV-1 integrase inhibitor. Used for Treatment of HIV-1 infection.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}